These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34890638)

  • 1. Effects of tyrosine kinase inhibitors on androgen, estrogen α, glucocorticoid and thyroid receptors.
    Kenda M; Avsec D; Zore T; Kogovšek E; Pečar Fonović U; Kos J; Bozovičar K; Bratkovič T; Karas Kuželički N; Žegura B; Filipič M; Sollner Dolenc M
    Toxicol Appl Pharmacol; 2022 Jan; 434():115818. PubMed ID: 34890638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of central nervous system drugs on androgen, estrogen α, glucocorticoid, and thyroid receptors.
    Kenda M; Zore T; Sollner Dolenc M
    Chem Biol Interact; 2022 Aug; 363():110030. PubMed ID: 35760085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triclocarban, Triclosan, Bromochlorophene, Chlorophene, and Climbazole Effects on Nuclear Receptors: An
    Kenda M; Karas Kuželički N; Iida M; Kojima H; Sollner Dolenc M
    Environ Health Perspect; 2020 Oct; 128(10):107005. PubMed ID: 33064576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
    Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
    Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of endocrine activities of ellagic acid and urolithins using reporter gene assays.
    Gramec Skledar D; Tomašič T; Sollner Dolenc M; Peterlin Mašič L; Zega A
    Chemosphere; 2019 Apr; 220():706-713. PubMed ID: 30611068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine Activity of AVB, 2MR, BHA, and Their Mixtures.
    Klopcic I; Dolenc MS
    Toxicol Sci; 2017 Mar; 156(1):240-251. PubMed ID: 28115641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
    Wilson VS; Bobseine K; Lambright CR; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
    Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear hormone receptor activity of polybrominated diphenyl ethers and their hydroxylated and methoxylated metabolites in transactivation assays using Chinese hamster ovary cells.
    Kojima H; Takeuchi S; Uramaru N; Sugihara K; Yoshida T; Kitamura S
    Environ Health Perspect; 2009 Aug; 117(8):1210-8. PubMed ID: 19672399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
    Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
    Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of tetrabromobisphenol A effects on human glucocorticoid and androgen receptors: A comparison of results from human- with yeast-based in vitro assays.
    Beck KR; Sommer TJ; Schuster D; Odermatt A
    Toxicology; 2016 Aug; 370():70-77. PubMed ID: 27693315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.
    Di Gion P; Kanefendt F; Lindauer A; Scheffler M; Doroshyenko O; Fuhr U; Wolf J; Jaehde U
    Clin Pharmacokinet; 2011 Sep; 50(9):551-603. PubMed ID: 21827214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TKI combination therapy: strategy to enhance dasatinib uptake by inhibiting Pgp- and BCRP-mediated efflux.
    D'Cunha R; Bae S; Murry DJ; An G
    Biopharm Drug Dispos; 2016 Oct; 37(7):397-408. PubMed ID: 27418107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of endocrine disruption potential of essential oils of culinary herbs and spices involving glucocorticoid, androgen and vitamin D receptors.
    Bartoňková I; Dvořák Z
    Food Funct; 2018 Apr; 9(4):2136-2144. PubMed ID: 29629442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
    Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
    Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
    Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
    Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity and potency of the retroprogesterone dydrogesterone in vitro.
    Rižner TL; Brožič P; Doucette C; Turek-Etienne T; Müller-Vieira U; Sonneveld E; van der Burg B; Böcker C; Husen B
    Steroids; 2011 May; 76(6):607-15. PubMed ID: 21376746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dual Androgen Receptor and Glucocorticoid Receptor Antagonist CB-03-10 as Potential Treatment for Tumors that have Acquired GR-mediated Resistance to AR Blockade.
    Rosette C; Agan FJ; Rosette N; Mazzetti A; Moro L; Gerloni M
    Mol Cancer Ther; 2020 Nov; 19(11):2256-2266. PubMed ID: 32847976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
    Isikbay M; Otto K; Kregel S; Kach J; Cai Y; Vander Griend DJ; Conzen SD; Szmulewitz RZ
    Horm Cancer; 2014 Apr; 5(2):72-89. PubMed ID: 24615402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
    Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.